MK-677 user experiences: what users themselves report

Users’ own accounts, not research. The accounts are self-selected and prove neither that it works nor that it is safe.

This page does not list users’ doses or sellers, and no figure on it is a recommendation. Doses used in studies, with sources: MK-677 dosage in studies.

In short

Of 80 people, 43 (54%) said MK-677 brought some benefit and 50 (63%) some harm.

Where the accounts come from and how we read them

Sources: the Reddit forums r/mk677 (63 accounts), r/Peptides (12), r/Biohackers (10) and r/Nootropics (2), 17 Oct 2024 to 10 Sep 2026. The posts were retrieved from a public Reddit archive. From first-person posts about MK-677, 300 were picked at random, and every one was read.

Coding: for each account we recorded the route, reported benefits and harms, how strong a harm was, whether and why the person stopped, length of use and other substances used at the same time. We kept accounts that reported some effect, some harm, or no effect. Questions and plans were left out. A harm was recorded when the person reported it during use, even if the cause was uncertain. Several posts by one person count as one person. One person can mention several things, so the shares in the tables do not add up to 100.

Check: an AI model read and classified the posts following written instructions. A second, separate AI run classified a random tenth (30 posts) again without seeing the first classification. The main fields matched: 28/30 (93%). One post looked like marketing and is not in the figures.

Whose accounts these are: routes mentioned: by mouth 80; the others did not say. The figures describe the writers and are not a recommendation. The products were not verified, so we do not know what people actually took.

Did MK-677 help? The overall picture

Of 80 people, 25 (31%) reported benefit only, 18 (23%) both benefit and harm, 32 (40%) harm only and 5 (6%) neither.

Stopping. 3 people (4%) said they stopped or paused: 3 because of harms and 0 because they noticed no effect or for another reason.

Share = people / 80.
Overall picture: benefit, harm or neitherPeopleShare
Benefit only2531%
Both benefit and harm1823%
Harm only3240%
Neither benefit nor harm56%

Most common reported benefits

Of 80 people. 43 (54%) mentioned some benefit; the table lists every benefit reported.

ReportedPeopleShare
Better sleep2025%
More appetite or weight gain (wanted)1114%
Muscle or strength1114%
Faster recovery911%
Energy or alertness45%
IGF-1 rose on a lab test34%
Mood or wellbeing34%
Less joint or other pain23%
Other benefit810%

Share = people / 80.

Most common reported harms

Of 80 people. 50 (63%) mentioned some harm; 4 said explicitly they had none.

ReportedPeopleShare
Higher blood sugar or insulin resistance1215%
Strong hunger (unwanted)1114%
Nausea or stomach upset79%
Fatigue or lethargy68%
Water retention or swelling68%
Sleep problems56%
Anxiety, irritability or low mood45%
Joint or muscle pain34%
Heart or blood pressure23%
Headache11%
Prolactin, cortisol or breast tissue symptoms11%
Other, rarer harm1215%

Share = people / 80.

How severe were the harms?

Of the 50 people who described how strong a harm was, 35 (70%) described it as mild, 13 (26%) as clearly bothersome and 2 (4%) as severe. The strength is the writer's own description, not a doctor's assessment.

Share = people / 50.
Strength of the harm as the writer described itPeopleShare
Mild: minor and manageable3570%
Clearly bothersome: several days, sleep or work affected1326%
Severe: emergency visit, hospital or unable to function24%

Harms known from research and regulators: What side effects does MK-677 have?

How long did people use MK-677?

59 of 80 people (74%) said how long they had been using it at the time of writing. Where one person wrote several posts, the longest stated time counts.

Share = people / 59.
Stated length of usePeopleShare
Under a week2237%
1-4 weeks2237%
1-3 months1119%
Over 3 months47%

Many people post partway through, often in the first days or as soon as harms start, so short times are over-represented. The numbers describe the writers; they do not say how long it should be used.

Other substances at the same time

8 of 80 people (10%) used other substances at the same time. The most common: testosterone therapy (2), arimistane (1), BPC-157 (1), cardarine (1), enclomiphene (1) and 5 more equally common. Then the account cannot tell which substance had the effect.

About dosing

We do not repeat the amounts or ways of use people mention, and we give no dosing or how-to instructions. A safe dose is not known. Doses used in studies, with sources: MK-677 dosage in studies. Legal status: Is MK-677 legal in Finland?

What can be concluded?

The most common reported benefit was better sleep and the most common harm a rise in blood sugar, and many also reported unwanted hunger. Because other substances were rarely used, the accounts describe this substance more clearly than most other summaries.

The accounts prove neither that it works nor that it is safe. The writers are self-selected, the product contents are unknown, many used several substances at once, and placebo effects can be large. The research and its evidence levels: MK-677: what the research shows.

Quotes

Short excerpts in the writers’ own words. Writers’ names and links are not shown. We picked quotes from every group: benefit, both benefit and harm, no effect, harms and people who stopped.

Other summaries made with the same method: BPC-157 user experiences, Ipamorelin user experiences, CJC-1295 user experiences, Tesamorelin user experiences, Sermorelin user experiences, AOD-9604 user experiences, CJC-1295 + ipamorelin blend user experiences and user experiences with collagen and skin peptides.

Content is general information about research, not medical advice. If you have symptoms, contact a healthcare professional.